Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Patent blue v is a synthetic triphenylmethane dye used primarily in medicine to visualize lymphatic vessels, arterial territories, and lymph nodes prior to biopsy in certain cancers, such as during sentinel node mapping. It is also used for radiological examinations and as a diagnostic aid. The dye binds specifically to albumin, allowing it to travel through the lymphatic system after injection. In addition to its medical uses, it serves as a food coloring (E131) and pH/redox indicator in laboratory settings. Developed by Guerbet and approved since at least 1979, patent blue v is excreted mainly via urine and bile with an elimination half-life of about 24–48 hours[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Patent blue V.